The over-expression of SOAT1 has been recognized as an indicator of tumor progression in glioblastoma, pancreatic cancer, and prostate cancer [68–70].The high expression of SOAT1 was positively correlated with poor prognosis of HCC patients [71]. Here, SOAT1 is linked to prostate carcinoma.